(Total Views: 98)
Posted On: 08/06/2025 9:10:06 AM
Post# of 107985
$ADTX Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technology for Early Detection of Cancers and Other Diseases
https://finance.yahoo.com/news/aditxt-subsidi...00137.html
(0)
(0)
